Early research (Phase 1)WithdrawnNCT01039610
What this trial is testing
A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.
Who this might be right for
Infections, Bacterial
GlaxoSmithKline